Mevalonate kinase deficiency and Dutch type periodic fever

被引:0
|
作者
Frenkel, J
Houten, SM
Waterham, HR
Wanders, RJA
Rijkers, GT
Kimpen, JLL
Duran, R
Poll-The, BT
Kuis, W
机构
[1] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Gen Pediat, NL-3508 AB Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Immunol, NL-3508 AB Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Wilhelmina Childrens Hosp, Dept Metab Disorders, NL-3508 AB Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem & Pediat, NL-1105 AZ Amsterdam, Netherlands
关键词
fever; IgD; hypergammaglobulinemia; mevalonate kinase; mevalonic acid; familial Mediterranean fever; periodicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dutch type periodic fever (DPF) is an autosomal recessive hereditary fever syndrome. Cases have been reported worldwide, the majority from France and The Netherlands. From infancy the patients suffer fever attacks that recur every 2-8 weeks, often precipitated by immunizations, infections or emotional stress. Fever lasts 2-7 days and can be accompanied by malaise, headache diarrhea, abdominal pain vomiting, skin rashes, arthralgia, arthritis, tender lymphadenopathy: hepatosplenomegaly and oral and genital ulcers. Labarotory evaluation during fever shows granulocytosis and elevated acute phase reactants. DPF is caused by a deficiency of the enzyme mevalonate kinase (MK). Besides DPE, the spectrum of MK deficiency includes a severe phenotype, mevalonic aciduria (MA). MA patients have less residual MK activity leading to substantially higher urinary, mevalonic acid excretion than in DPF. Mevalonic aciduria is characterized by mental retardation and dysmorphic features in addition to the clinical features of DPE At the genomic level, several mutations of varying severity have been identified The DPF phenotype is caused by one particular mild missense mutation. Most patients are compound heterozygotes for this mutation and a more severe mutation. The mechanism by which MK deficiency lends to fever is not understood. The vast majority of DPF patients have persistently, elevated serum IgD and can be classified as having hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). Conversely, most HIDS patients have MK deficiency and hence DPF, but the two disorders do not overlap entirely.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 50 条
  • [1] Mevalonate Kinase Deficiency as Cause of Periodic Fever in Two Siblings
    Correa, Alec Reginald Errol
    Gupta, Neerja
    Bagri, Narendra
    Vignesh, Pandiarajan
    Alam, Seema
    Yamaguchi, Seiji
    INDIAN PEDIATRICS, 2020, 57 (02) : 180 - 181
  • [2] Mevalonate Kinase Deficiency as Cause of Periodic Fever in Two Siblings
    Alec Reginald Errol Correa
    Neerja Gupta
    Narendra Bagri
    Pandiarajan Vignesh
    Seema Alam
    Seiji Yamaguchi
    Indian Pediatrics, 2020, 57 : 180 - 181
  • [3] Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinaemia D
    Di Rocco, M
    Caruso, U
    Waterham, HR
    Picco, P
    Loy, A
    Wanders, RJA
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (03) : 411 - 412
  • [4] RECURRENT FEVER IN CHILDREN: WHY NOT A MEVALONATE KINASE DEFICIENCY?
    Ouahbi, K.
    Gacem, O.
    Boukandoura, F.
    Benmekhmouf, H.
    Hamadouche, N.
    Hadjyoucef, N.
    Chouiki, H.
    Mehaba, N.
    Abba, K.
    Mansouri, N.
    Achir, M.
    Ladj, M. S.
    RHEUMATOLOGY, 2021, 60 : V30 - V30
  • [5] Two cases of periodic fever syndrome with coexistent mevalonate kinase and Mediterranean fever gene mutations
    Cakan, Mustafa
    Aktay-Ayaz, Nuray
    Keskindemirci, Gonca
    Karadag, Serife Gul
    TURKISH JOURNAL OF PEDIATRICS, 2017, 59 (04) : 467 - 470
  • [6] Hyperimmunoglobulinemia and periodic fever syndrome due to mutations in the gene mevalonate kinase (MVK).
    Poll-The, BT
    Houten, SM
    Frenkel, J
    Kuis, W
    Duran, M
    de Koning, TJ
    van Royen-Kerkhof, A
    Romeijn, GJ
    Dorland, L
    Rijkers, GT
    Waterham, HR
    Wanders, RJA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A95 - A95
  • [7] Mevalonate kinase deficiency and inflammation
    Frenkel, J
    Kuijk, LM
    Schellens, IM
    Mandey, SH
    Rijkers, GT
    Waterham, HR
    Kuis, W
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 3 - 4
  • [8] Mevalonate kinase deficiency and autoinflammation
    Hager, Elizabeth J.
    Gibson, K. Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18): : 1871 - 1872
  • [9] Mevalonate kinase deficiency nomenclature
    Stoffels, Monique
    van der Meer, Jos W. M.
    Simon, Anna
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (02) : 295 - 296
  • [10] Mevalonate kinase deficiency in 2016
    Galeotti, C.
    Georgin-Lavialle, S.
    Sarrabay, G.
    Touitou, I.
    Kone-Paut, I.
    REVUE DE MEDECINE INTERNE, 2018, 39 (04): : 265 - 270